News

AddToAny

Google+ Facebook Twitter Twitter

New treatment to shrink prostate

A new treatment for non-cancerous enlargement of the prostate has been recommended for use by the NHS.

The National Institute for Health and Care Excellence has approved prostate artery embolisation (PAE).

The treatment blocks some of the blood supply to the prostate using tiny synthetic beads, causing the troublesome tissue to shrink and die.

It involves inserting hundreds of very small (0.2mm) plastic beads into a blood vessel in the groin and is carried out under local anaesthetic, with no overnight stay in hospital.

A total of 18 centres in the UK have already been offering the treatment as part of a trial.

In trials, PAE was compared to conventional prostate surgery and was found to be safe.

It also provided a clinically and statistically significant improvement in symptoms and quality of life for men with enlarged prostate.

Dr Nigel Hacking, Consultant Interventional Radiologist at University Hospital Southampton, said: “Results from the study show PAE can help large numbers of men suffering with the symptoms of an enlarged prostate. It is a good option for men who are not yet ready to undergo more invasive prostate surgery.”

bit.ly/BS_JuneNews01

Related Articles

Image Credit | The Red Dress

Voyage through the colon: The rise of non-invasive diagnostics

Non-invasive testing has come a long way over recent decades. Here we look at a pioneering colon capsule endoscopy project that is underway and cast an eye over the history of this growing field.

Medical conference, educational meeting of doctors scientists vector illustration.CREDIT - Shutterstock-1635771265

The Big Question: Modernising Scientific Careers

This month we ask: Modernising Scientific Careers was hoped to address skills shortages by standardising education and training pathways. How successful in this do you think it has been?

Liquid biopsy evaluation-CREDIT - syantra-inc-20211117

Liquid biopsy evaluation

Researchers have received a $2.4m grant from the U.S. Department of Defense Breast Cancer Research Program to validate a new blood test for the early detection of breast cancer.

David Wells

The adoption of home testing

IBMS Chief Executive David Wells on ensuring home testing is implemented in a safe, effective and ethical manner.

Top